Close Menu

NEW YORK (GenomeWeb) — Arcis Biotechnology and Andrew Alliance announced today that they have signed an agreement to comarket their respective technologies for automated nucleic acid stabilization and preparation.

Under the terms of the deal, the partners will promote the use of Arcis' reagents for DNA and RNA preparation with Andrew Alliance platforms, including the Andrew+ pipetting robot, and its OneLab lab protocol design and execution software.

Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.